# KADCYLA

NDC: 50242-088
Generic name: ADO-TRASTUZUMAB EMTANSINE
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20130222

FDA application: BLA125427

## Active ingredients

- TRASTUZUMAB EMTANSINE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-088"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-088
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e